AstraZeneca Could Price Poor Out Of COVID Vaccine After Pandemic, Warns Trial Volunteer

The pharma giant said it was “too early to comment on pricing post-pandemic” for the coronavirus drug it is trialing.

No Responses to “AstraZeneca Could Price Poor Out Of COVID Vaccine After Pandemic, Warns Trial Volunteer”

Post a Comment